Cargando…
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medicat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835534/ https://www.ncbi.nlm.nih.gov/pubmed/35162405 http://dx.doi.org/10.3390/ijerph19031389 |
_version_ | 1784649457472634880 |
---|---|
author | Ceulemans, Michael Foulon, Veerle Panchaud, Alice Winterfeld, Ursula Pomar, Léo Lambelet, Valentine Cleary, Brian O’Shaughnessy, Fergal Passier, Anneke Richardson, Jonathan Luke Nordeng, Hedvig |
author_facet | Ceulemans, Michael Foulon, Veerle Panchaud, Alice Winterfeld, Ursula Pomar, Léo Lambelet, Valentine Cleary, Brian O’Shaughnessy, Fergal Passier, Anneke Richardson, Jonathan Luke Nordeng, Hedvig |
author_sort | Ceulemans, Michael |
collection | PubMed |
description | Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medications used by pregnant and breast-feeding women during the first pandemic wave. Factors associated with medication use were estimated by logistic regression. In total, 8378 women participated (i.e., 3666 pregnant and 4712 breastfeeding women). Most responses were collected in Norway (34%) and The Netherlands (28%), followed by Switzerland (19%), Ireland (17%) and UK (2%). Participants were more often professionally active and more often had a higher educational level compared to the general birthing population in each country. Overall, approximately 60% of women reported having used at least 1 medication in the preceding 3 months. Daily and occasional use was reported by 34% and 42% of pregnant and 29% and 44% of breastfeeding women. The most prevalent ATC (Anatomical Therapeutic Chemical) categories were the nervous system, the respiratory system, the alimentary tract/metabolism, and the musculo-skeletal system. Paracetamol, ibuprofen, antacids, and cetirizine were the most frequently used medications. The rate of antibacterial use was lower than previously reported. Having a chronic illness, country, maternal age, SARS-CoV-2 testing, professional status and time since delivery were associated with medication use. In conclusion, perinatal medication use was highly prevalent during the first pandemic wave, underlining the importance of maintaining counseling efforts on medication use, even in times of disrupted healthcare services and/or limited resources. |
format | Online Article Text |
id | pubmed-8835534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88355342022-02-12 Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries Ceulemans, Michael Foulon, Veerle Panchaud, Alice Winterfeld, Ursula Pomar, Léo Lambelet, Valentine Cleary, Brian O’Shaughnessy, Fergal Passier, Anneke Richardson, Jonathan Luke Nordeng, Hedvig Int J Environ Res Public Health Article Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medications used by pregnant and breast-feeding women during the first pandemic wave. Factors associated with medication use were estimated by logistic regression. In total, 8378 women participated (i.e., 3666 pregnant and 4712 breastfeeding women). Most responses were collected in Norway (34%) and The Netherlands (28%), followed by Switzerland (19%), Ireland (17%) and UK (2%). Participants were more often professionally active and more often had a higher educational level compared to the general birthing population in each country. Overall, approximately 60% of women reported having used at least 1 medication in the preceding 3 months. Daily and occasional use was reported by 34% and 42% of pregnant and 29% and 44% of breastfeeding women. The most prevalent ATC (Anatomical Therapeutic Chemical) categories were the nervous system, the respiratory system, the alimentary tract/metabolism, and the musculo-skeletal system. Paracetamol, ibuprofen, antacids, and cetirizine were the most frequently used medications. The rate of antibacterial use was lower than previously reported. Having a chronic illness, country, maternal age, SARS-CoV-2 testing, professional status and time since delivery were associated with medication use. In conclusion, perinatal medication use was highly prevalent during the first pandemic wave, underlining the importance of maintaining counseling efforts on medication use, even in times of disrupted healthcare services and/or limited resources. MDPI 2022-01-26 /pmc/articles/PMC8835534/ /pubmed/35162405 http://dx.doi.org/10.3390/ijerph19031389 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ceulemans, Michael Foulon, Veerle Panchaud, Alice Winterfeld, Ursula Pomar, Léo Lambelet, Valentine Cleary, Brian O’Shaughnessy, Fergal Passier, Anneke Richardson, Jonathan Luke Nordeng, Hedvig Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title | Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title_full | Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title_fullStr | Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title_full_unstemmed | Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title_short | Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries |
title_sort | self-reported medication use among pregnant and breastfeeding women during the covid-19 pandemic: a cross-sectional study in five european countries |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835534/ https://www.ncbi.nlm.nih.gov/pubmed/35162405 http://dx.doi.org/10.3390/ijerph19031389 |
work_keys_str_mv | AT ceulemansmichael selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT foulonveerle selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT panchaudalice selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT winterfeldursula selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT pomarleo selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT lambeletvalentine selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT clearybrian selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT oshaughnessyfergal selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT passieranneke selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT richardsonjonathanluke selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries AT nordenghedvig selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries |